From Weeks to Seconds: What can virtual experimentation do for Bioprocess Development?

In biopharma, time is always ticking. New therapies and new technologies are pushing boundaries, yet one critical piece of the puzzle often lags behind: bioprocess development. For decades, scientists have worked within the same boundaries. You set up your bioreactor, feed the cells, wait for days or weeks, and then hope the data shows the […]

Preventing failures before they start: How SimCell protects your process

Bioprocess failures rarely strike without warning. They build slowly, sometimes imperceptibly. A slightly delayed nutrient feed. A subtle dip in oxygen transfer. A parameter drifting just enough to push a process off course. Traditional monitoring tools often detect trouble only after it has become visible in critical quality attributes. By then, the batch is at […]

From Chaos to Clarity: How AI tackles the Butterfly Effect in Bioprocessing

A single adjustment in a bioprocess might feel insignificant. Yet in practice, a small feed change on day three could ripple forward to alter lactate accumulation, disrupt glycan profiles, and push an entire batch outside of critical specifications. This phenomenon—the butterfly effect in bioprocessing—remains one of the biggest challenges in modern manufacturing. Traditional methods often […]

Neuroevolution AI: AI-Driven Bioprocessing, Evolved

At AnalysisMode, we don’t just build AI—we engineer intelligence that evolves. Bioprocess development is complex, unpredictable, and dynamic. So why rely on static models? Our Neuroevolution framework doesn’t just analyze data; it learns, adapts, and optimizes continuously, ensuring our AI is always in sync with real-world bioprocessing challenges. AI Technology: Smarter, Faster, and Built for […]

Why AI is biopharma’s best bet for faster time-to-market?

Bringing a new drug to market is an intricate and costly process. On average, it takes 10 to 15 years and costs between $314 million and $4.46 billion to develop a new therapy, depending on the therapeutic area and trial complexity. These long timelines not only delay patient access to life-saving treatments but also drive […]

LIBRA: Advancing nutrient monitoring with Raman and aMZI Technologies

Introduction Nutrient monitoring in bioreactors is critical for ensuring optimal growth and productivity. However, traditional methods often lack the precision and real-time capabilities required for modern bioprocessing. The LIBRA project is changing the game by integrating Raman Spectroscopy and Asymmetric Mach–Zehnder Interferometers (aMZI) into a powerful, compact system designed to deliver accurate, real-time nutrient analysis. […]

How AI supercharges bioprocess DoE strategies

Design of Experiments (DoE) is a foundational tool in bioprocess development, offering scientists a structured approach to studying the effects of multiple variables on process outcomes. By exploring parameter interactions and their influence on critical quality attributes (CQAs) and critical process parameters (CPPs), DoE plays a vital role in optimizing bioprocesses. However, traditional DoE methods […]

LIBRA: Shaping the future of bioreactors

Introduction Bioprocessing industries are rapidly evolving, and precision in monitoring critical parameters is more important than ever. The LIBRA project, funded by Horizon Europe, is paving the way for transformative changes in bioreactor monitoring by combining cutting-edge AI and light-based sensing technologies. This revolutionary project aims to streamline nutrient and pathogen detection in real-time, offering […]

Demystifying Digital Twins: How They Support Biopharma Innovation

Digital twins are becoming essential tools for scientists in biopharma, offering a way to understand and optimize bioprocesses virtually. Unlike static models, digital twins are dynamic, integrating real-time data from sensors, historical runs, and predictive algorithms to simulate process behavior. What Are Digital Twins? A digital twin is a virtual replica of a physical process […]

Overcoming Bioprocessing challenges with AI-powered solutions

Biopharma process development is a complex and dynamic field where scientists face a multitude of challenges. Whether it’s ensuring batch-to-batch consistency, scaling up processes to production levels, or meeting regulatory expectations, these hurdles can significantly slow down progress and increase costs. Artificial intelligence (AI) has emerged as a transformative tool to tackle these challenges, enabling […]